John D. Tamerius
2011
In 2011, John D. Tamerius earned a total compensation of $759K as SVP, Clinical/Regulatory at Quidel, a 26% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $95,561 |
|---|---|
| Option Awards | $174,400 |
| Salary | $280,464 |
| Stock Awards | $114,800 |
| Other | $93,768 |
| Total | $758,993 |
Tamerius received $280.5K in salary, accounting for 37% of the total pay in 2011.
Tamerius also received $95.6K in non-equity incentive plan, $174.4K in option awards, $114.8K in stock awards and $93.8K in other compensation.
Rankings
In 2011, John D. Tamerius' compensation ranked 6,644th out of 10,747 executives tracked by ExecPay. In other words, Tamerius earned more than 38.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,644 out of 10,747 | 38th |
Division Manufacturing | 2,409 out of 3,960 | 39th |
Major group Chemicals And Allied Products | 566 out of 1,033 | 45th |
Industry group Drugs | 374 out of 781 | 52nd |
Industry In Vitro and In Vivo Diagnostic Substances | 16 out of 43 | 63rd |
Source: SEC filing on April 1, 2014.
Tamerius' colleagues
We found six more compensation records of executives who worked with John D. Tamerius at Quidel in 2011.
2011
Douglas Bryant
Quidel
Chief Executive Officer
2011
Timothy Stenzel
Quidel
Chief Scientific Officer
2011
Robert Bujarski
Quidel
General Counsel
2011
Randall Steward
Quidel
Chief Financial Officer
2011
John Radak
Quidel
Chief Financial Officer
2011
Mark Smits
Quidel